I wrote this one in 2012. The relevance to the “current Ebola crisis” should be obvious, especially since it seems that every pharmaceutical company now working overtime on Ebola drugs and vaccines is receiving funding from the Pentagon.
Who knew the Pentagon had muscled into the US vaccine program?
DARPA (Defense Advanced Research Projects Agency) has been doing research on vaccine production. They’ve found a way to produce flu vaccines a lot faster than Big Pharma.
DARPA Effort Speeds Biothreat Response (Nov. 2, 2010, by Cheryl Pellerin, American Forces Press Service)
DARPA’s Blue Angel – Pentagon prepares millions of vaccines against future global flu (28 July, 2012,)
Utilizing vaccines grown on tobacco cells, instead of the traditional chicken eggs, DARPA has turned out a staggering 10 million doses of flu vaccine in just one month.
This “Blue Angel” project, as it’s called, suddenly puts the Pentagon in the forefront of the vaccine business. The big question is: why is the Army involved in vaccines at all? And the answer is no surprise. According to DARPA, it’s all about readiness in containing bio-threats. Translated, that means terrorist attacks that could use flu viruses.
This is a sinister development. It creates a potential scenario in which the military can invent the “bio-threat” and then step in and provide the solution. It doesn’t really matter whether the bio-threat is real or imaginary.
The threat would offer the chance to initiate a martial-law scenario, after which the military vaccine would be made mandatory, destroying the right of each state in the union to permit, as is now the case, people to opt out of vaccination on religious, medical, or ethical grounds.
The Pentagon is famous for developing weapons and then lobbying for battlefield opportunities to use them. This is part and parcel of their “war is forever” mentality. Well, in this case, the vaccine becomes the defensive weapon, and you can be sure the Pentagon will strive to deploy it in a situation that “demands it”—a chilling prospect. …